Novel direct effects of SGLT2 inhibitor, Canagliflozin, on myocardial redox state in humans
Kondo H., Akoumianakis I., Akawi N., Cristina M., Herdman L., Badi I., Kotanidis C., Akbar N., Antonopoulos A., Oikonomou E., Chuaiphichai S., Channon K., Antoniades C.